Yueming Qian, MD, PhD, Director of Process Development at
Pre-Pivotal Drug Substance Technologies of Amgen Inc. With a career that began
in studying drug targets, Dr. Qian has since specialized in biologics
development and production. His areas of expertise include cell line
development and cell culture process development. He also served as a liaison
between discovery and process development, coordinating program advancement
from molecule selection to modality-appropriate cell line development.
Yueming Qian, MD, PhD, Director of Process Development at
Pre-Pivotal Drug Substance Technologies of Amgen Inc. With a career that began
in studying drug targets, Dr. Qian has since specialized in biologics
development and production. His areas of expertise include cell line
development and cell culture process development. He also served as a liaison
between discovery and process development, coordinating program advancement
from molecule selection to modality-appropriate cell line development.